Literature DB >> 28450404

Oral contraceptive use is a provoking factor for venous thromboembolism.

Saskia Middeldorp1, Alfonso Iorio2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28450404     DOI： 10.1136/bmj.j2073

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

Review 1.  Sex matters: Practice 5P's when treating young women with venous thromboembolism.

Authors:  Ingrid M Bistervels; Luuk J J Scheres; Eva N Hamulyák; Saskia Middeldorp
Journal:  J Thromb Haemost       Date:  2019-07-23       Impact factor: 5.824

2.  Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).

Authors:  Jasmijn F Timp; Sigrid K Braekkan; Willem M Lijfering; Astrid van Hylckama Vlieg; John-Bjarne Hansen; Frits R Rosendaal; Saskia le Cessie; Suzanne C Cannegieter
Journal:  PLoS Med       Date:  2019-10-11       Impact factor: 11.069

3.  Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: Systematic review and meta-analysis.

Authors:  Hanke M G Wiegers; Jannet Knijp; Nick van Es; Michiel Coppens; Stephan Moll; Frederikus A Klok; Saskia Middeldorp
Journal:  J Thromb Haemost       Date:  2022-02-13       Impact factor: 16.036
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.